Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome.
about
Pathophysiology of locus ceruleus neurons in a mouse model of Rett syndromeEmerging pharmacotherapies for neurodevelopmental disordersBioaminergic neuromodulation of respiratory rhythm in vitroTargeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromesRett Syndrome: Reaching for Clinical TrialsA BDNF loop-domain mimetic acutely reverses spontaneous apneas and respiratory abnormalities during behavioral arousal in a mouse model of Rett syndrome.Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome.Preclinical research in Rett syndrome: setting the foundation for translational success.Improvement of the Rett syndrome phenotype in a MeCP2 mouse model upon treatment with levodopa and a dopa-decarboxylase inhibitorIntrinsic membrane properties of locus coeruleus neurons in Mecp2-null mice.Effect of Sarizotan, a 5-HT1a and D2-like receptor agonist, on respiration in three mouse models of Rett syndromeβ2-Adrenergic receptor agonist ameliorates phenotypes and corrects microRNA-mediated IGF1 deficits in a mouse model of Rett syndromePontine norepinephrine defects in Mecp2-null mice involve deficient expression of dopamine beta-hydroxylase but not a loss of catecholaminergic neurons.Is X-linked methyl-CpG binding protein 2 a new target for the treatment of Parkinson's diseaseAcetyl-L-carnitine improves behavior and dendritic morphology in a mouse model of Rett syndrome.Experimental models of Rett syndrome based on Mecp2 dysfunction.Habituation without NMDA Receptor-Dependent Desensitization of Hering-Breuer Apnea Reflex in a Mecp2 Mutant Mouse Model of Rett SyndromeThe disruption of central CO2 chemosensitivity in a mouse model of Rett syndrome.Regulation of respiratory-related hypoglossal motor output by α₁ adrenergic and serotonin 5-HT₃ receptor activation in isolated adult turtle brainstemsRett syndrome: genes, synapses, circuits, and therapeuticsPartial rescue of Rett syndrome by ω-3 polyunsaturated fatty acids (PUFAs) oilLoss of MeCP2 Causes Urological Dysfunction and Contributes to Death by Kidney Failure in Mouse Models of Rett Syndrome.Pharmacological treatment with mirtazapine rescues cortical atrophy and respiratory deficits in MeCP2 null mice.Correcting deregulated Fxyd1 expression ameliorates a behavioral impairment in a mouse model of Rett syndrome.Early intervention with psychostimulants or antidepressants to increase methyl-CpG-binding protein 2 (MeCP2) expressions: a potential therapy for Rett syndrome.Peripheral administration of brain-derived neurotrophic factor to Rett syndrome animal model: a possible approach for the treatment of Rett syndromeRett syndrome: recent research progress.Neural control of breathing: insights from genetic mouse models.Breathing dysfunction in Rett syndrome: understanding epigenetic regulation of the respiratory networkAn optogenetic mouse model of rett syndrome targeting on catecholaminergic neurons.Neuromodulation and the orchestration of the respiratory rhythm.Evaluation of current pharmacological treatment options in the management of Rett syndrome: from the present to future therapeutic alternatives.Breathing challenges in Rett syndrome: lessons learned from humans and animal models.Effects of early-life exposure to THIP on phenotype development in a mouse model of Rett syndrome.Breathing disorders in Rett syndrome: progressive neurochemical dysfunction in the respiratory network after birthWhen norepinephrine becomes a driver of breathing irregularities: how intermittent hypoxia fundamentally alters the modulatory response of the respiratory network.Central pattern generator for locomotion: anatomical, physiological, and pathophysiological considerations.Genetic diseases: congenital central hypoventilation, Rett, and Prader-Willi syndromes.Rett syndrome and MeCP2.Breathing abnormalities in animal models of Rett syndrome a female neurogenetic disorder.
P2860
Q24610771-B4FAE7BA-E538-4606-9379-58E05CCC5252Q24619170-6B1ACC73-4AFE-4AE9-A584-1744D256AFD1Q24643036-F87CB98C-F5CA-4859-B851-08293DE585D6Q27023257-16E29692-F6F9-4F93-9ED6-FF0243AA1969Q27337778-3807014D-4121-49C8-B263-A4ACA91FFB11Q30431760-51192520-E36C-4202-9558-0FA24E8646F5Q30524829-C8483944-17EF-4C56-912F-4FE47EE6C584Q30527828-3A81AE29-9153-414D-90D3-AF99BB07DA6DQ30593615-1AC31653-6DA9-4B83-9E57-B7F82D1324D6Q33727650-734BECC9-1E33-4B17-B5C0-AFA2F6351D5DQ33799538-6BA90C63-6877-41E4-BA6E-4741DD025716Q33919634-8DA5E57F-7B1B-4BA9-A933-F72EC2E14EA8Q34044885-6DCE9011-F05E-41F6-B3EA-F498E1FE0F28Q34094521-EDBCF0CA-B22D-4F94-95E0-745229DAE60FQ34507396-6B35B084-EFF6-4181-8F6C-FEE823131C39Q34686591-F87D3DAA-19E1-459B-BC1D-8E9283E6CFB8Q34988543-867006E0-DE9B-40DD-8DCD-22D810AC274EQ35216828-FA578FBC-55C7-4498-8339-8605EB98A4C6Q35926203-E6C8D3D2-4B8F-4CF8-AE2B-3F6783192772Q35942447-27E045E7-7C05-4F88-83DA-923096B54E79Q36049510-7D4722EB-A1C2-4390-BFFE-70BBCB03957FQ36187325-E67BB40F-C5BB-43B6-9F79-04E3F863CACBQ36501038-A1E9CE7F-FC55-4600-B1C4-87D592BD9FF9Q36565518-805D6EC0-A6FA-4ADB-B12D-857E49D476A3Q36577177-B464FB72-C691-44C4-89F5-7670362C7C3BQ36577222-DA0C01AD-8DA1-4007-B6F8-C2DC32BE6F80Q37023198-7FD33B97-356D-4E8F-9689-53CB5CDFA66FQ37064742-2887338D-F8EF-4E99-BE4B-84663093A3D9Q37148672-4589A752-6BB8-4D80-97FD-35B1A333D97FQ37187907-57883D9E-8D03-47A7-A708-AE2361051ED3Q37207464-047EAF8F-C29F-47F4-951A-19825480CC5CQ37213531-C8A731A3-7976-4226-989F-D96736735E1DQ37265909-60C8D571-F183-4162-8C76-BF9232EA9C29Q37349496-88A3B54C-BF77-42F9-9B85-43CE924DE751Q37379871-6878AD26-8D84-4D7B-A262-8D3F79903CF9Q37399949-D0B1DFC4-0606-48BF-93B7-74F128D69BECQ38081065-C72CCDCD-7AD9-4943-A58E-410E6FF73229Q38110760-1709512A-76BB-4D3B-85CE-538C22C8AD2BQ38194967-910B1F06-A976-4F3D-86CE-F3CB52A05907Q39019145-CA93A8DE-2A21-4F40-B25B-58EAC761A193
P2860
Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Treatment with desipramine imp ...... mouse model for Rett syndrome.
@en
Treatment with desipramine imp ...... mouse model for Rett syndrome.
@nl
type
label
Treatment with desipramine imp ...... mouse model for Rett syndrome.
@en
Treatment with desipramine imp ...... mouse model for Rett syndrome.
@nl
prefLabel
Treatment with desipramine imp ...... mouse model for Rett syndrome.
@en
Treatment with desipramine imp ...... mouse model for Rett syndrome.
@nl
P2093
P1476
Treatment with desipramine imp ...... mouse model for Rett syndrome
@en
P2093
Anne Moncla
Emmanuelle Dura
Josette Mancini
P304
P356
10.1111/J.1460-9568.2007.05466.X
P407
P577
2007-04-01T00:00:00Z